Verdezyne Sells One of Its Technologies to DuPont Industrial Biosciences

Verdezyne, an industrial biotechnology company based in Carlsbad, Calif., has sold its proprietary xylose isomerase technology to DuPont Industrial Biosciences for an undisclosed amount. Current investors in Verdezyne include BP Alternative Energy Ventures, DSM Venturing B.V., OVP Venture Partners and Monitor Ventures.

PEHUB Community

Join the 12505 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget